Recently, Scire et al' reported the presence of haploinsufficiency in chromosome 22q1 1 in two patients with hypoparathyroidism. We wish to report two further cases in which we analysed 22ql 1 deletion by FISH.
The two patients were ascertained through their idiopathic hypoparathyroidism. The table shows their main clinical features and laboratory findings. All probes used for FISH were cosmid clones. D0832 was kindly provided by S Halford (Institute of Child Health, London, UK). Cos71 was a cosmid clone separated from a microdissected chromosome 22ql 1 (Kurahashi et al, submitted). cH-KAD26 and cHKAD92 were provided by the In a preliminary observation on a small sample, among the 19 pedigrees of inherited disorders, 14 could be maternal in origin and three could be paternal in origin.5 More recently, Seaver et atl reported four cases of pulmonary atresia associated with maternal 22ql 1 deletion using the D22S624 dinucleotide repeat polymorphism.
A case of 22q1 1 deficiency with abnormal face and hypernasal speech, not accompanied by cardiac anomaly, thymic hypoplasia, cleft palate, or hypocalcaemia, has been reported.7 Nickel et atl reported three patients with meningomyelocele, congenital heart defect, and 22ql 1 deletion. These recent reports and our observations suggest that the CATCH 22 syndrome has a wider variability of clinical phenotype than previously reported. However, the range of the mild phenotype of this syndrome has not been delineated. The order of the chromosome 22ql 1 markers is tel-cos7l-cHKAD26-D0832-cen (Kurahashi et al, submitted). A distal marker, cHKAD9 assigned to 22ql3.3, was used as a control probe to identify the chromosome 22 homologues. D0832, cos7l, and cH-KAD26 were deleted in our patients. These findings are consistent with the presence of a 22ql1 deletion. The acronym CATCH 22 has been proposed to designate the variable expression of Cardiac anomaly, Abnormal face, Thymic hypoplasia, Cleft palate, and Hypocalcaemia, resulting from 22qll deletion.3 The 22qll deletion has been widely analysed in patients with conotruncal cardiac defect but not in patients with idiopathic hypoparathyroidism. We used three cosmid probes for the detection of haploinsufficiency of 22q1 1. All probes we used were deleted in all our patients. These findings suggested that some cases with idiopathic hypoparathyroidism are a part of the CATCH 22 syndrome. Isolated idiopathic hypoparathyroidism (without cardiac defect and thymic defect) occurs in 22ql 1 haploinsufficiency and one end of the spectrum of the CATCH 22 syndrome.
However, the reason for the clinical heterogeneity in CATCH 22 is not clear. Aetiologically DGS can occur because of teratogenic exposure (alcohol, maternal diabetes, retinoids).4 Therefore, an environmental factor may also play a role in the heterogeneity of clinical expression of the CATCH 22 syndrome. Also the parental origin of 22ql 1 deletion may influence the clinical phenotype. and also to examine the clinical and molecular correlations. YOSHIO 
